TIS 0.00% 0.0¢ tissue therapies limited

risks, page-28

  1. 120 Posts.
    December should see TIS step into another league, with the final trials both in Australia and Britain complete , should see it get the go ahead for marketing.
    Starting of 2011 we will see a flurry of ann.coming from the co. which could see many multiples of its current sp, i am hoping to see some cash flow by the end of june2011, and a divy by dec 2011, all going to plan , easily achievable for a co. with infinite potential.

    cheers
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.